The Effects of Ethanol on Intestinal Permeability and Gut Hormones
Not Applicable
Completed
- Conditions
- Incretin EffectInsulin ResistanceEthanol
- Registration Number
- NCT03348371
- Lead Sponsor
- University of Copenhagen
- Brief Summary
The aime of this study is to envsitigate if ethanol has an incretin effect. This is done by administration of ethanol orally vs. an isoethanolaemic i.v. infusion of ethanol.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 12
Inclusion Criteria
- Caucasian male between 20 and 50 years of age
- Body mass index (BMI) between 19 and 25 kg/m2
- Weekly alcohol intake of less than 14 units of alcohol (of 12 g)
- Normal fasting plasma glucose concentration (i.e. <6 mmol/l) and normal glycated haemoglobin A1c (HbA1c) (i.e. ≤42 mmol/mol)
- Normal haemoglobin
- Informed consent
Exclusion Criteria
- First-degree relatives with diabetes and/or liver disease
- Liver disease or other alcohol-related diseases, diabetes mellitus
- Liver disease (serum ALAT and/or serum ASAT >2 × normal values)
- Nephropathy (serum creatinine above normal range and/or albuminuria)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method Serum insulin level 2 month difference in serum insulin level between the two administration forms
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link ethanol consumption to incretin hormone secretion and intestinal permeability changes?
How does oral ethanol administration compare to intravenous infusion in modulating gut hormone release and insulin sensitivity?
Are there specific biomarkers that correlate with ethanol-induced incretin effects in patients with insulin resistance?
What are the potential adverse events associated with ethanol-induced intestinal permeability changes and how are they managed?
How do ethanol's effects on gut hormones compare to other incretin-enhancing therapies like GLP-1 receptor agonists?